Skip to main content
Clinical Trials/NL-OMON43616
NL-OMON43616CompletedPhase 4

DD-study: diet or diuretics for salt-sensitivity in chronic kidney disease - DD-Study

Erasmus MC, Universitair Medisch Centrum Rotterdam0 sites22 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Phase 4
Status
Completed
Enrollment
22

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
18 to 99 (—)

Inclusion Criteria

  • - Age > 18 years.
  • - Chronic kidney disease stage 3 or 4 (MDRD-GFR 15-60 ml/min)
  • - Use of any anti-hypertensive drugs
  • - No anti-hypertensive drugs but an average office systolic blood pressure > 140 mmHg (as measured by datascope)

Exclusion Criteria

  • - Salt-wasting chronic kidney disease
  • - Nephrotic syndrome
  • - Pregnant or breastfeeding women
  • - Life expectancy < 6 months
  • - Severe heart failure (NYHA III or IV) or liver cirrhosis with ascites and the inability to withdraw diuretics
  • - Rapidly declining kidney function with high likelihood of dialysis or kidney transplantation in the coming 4 months
  • - Kidney transplant recipients
  • - Use of immunosuppressive drugs
  • - Use of non-steroidal anti-inflammatory drugs
  • - Previous intolerance or allergy to hydrochlorothiazide or amiloride
  • - Serum sodium < 135 mmol/l
  • - Serum potassium < 3.5 mmol/l or > 5.0 mmol/l
  • - Inability to adhere to the study protocol (due to language, incapacitated subjects, subjects with intellectual disability)

Investigators

Similar Trials

DD-study: diet or diuretics for... | Clinical Trial